三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Questions and answers

What we know about the Omicron variant so far

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2021-11-30 18:15
Share
Share - WeChat
A medical worker prepares a dose of COVID-19 vaccine at a vaccination site in Pingxiang city, South China's Guangxi Zhuang autonomous region, Nov 16, 2021. [Xinhua/Cao Yiming]

Answers to commonly-asked questions about the Omicron variant of COVID-19.

Q: Where and when was Omicron first detected, and how far has it spread?

The B.1.1.529 variant was first identified in South Africa on Nov 9 and became the dominant strain in circulation in the Gauteng province of South Africa within two weeks. On Nov 26, the World Health Organization designated it the fifth variant of concern (VOC) and named it Omicron after the Greek letter. The virus did not necessarily originate in South Africa.

As of Nov 28, countries and regions including South Africa, Israel, Belgium, Italy, the United Kingdom, Austria and the Hong Kong Special Administrative Region, have reported cases of the new strain. No cases have been reported elsewhere in China as yet.

Q: How has it evolved?

Genome sequencing of the new variant shows that the number of mutations it carries are significantly higher than known strains in the past two years. These mutations are concentrated on the virus's spike protein.

Three scenarios likely explain its emergence:

1. The virus accumulated a large number of mutations through a persistent infection in an immunocompromised patient and spread as a new strain through a chance event;

2. The virus infected an animal group and as a result, evolved at a faster mutation rate. It then spilled over into the human population;

3. The new strain had already been circulating in places without sufficient monitoring systems for a long time, and earlier generations of the strain have been missed.

Q: Is it more transmissible?

There is no systematic data on the new strain's transmissibility, pathogenicity or its ability to evade immunity. But it contains key mutations observed in four other variants of concern — Alpha, Beta, Gamma and Delta — as well as mutations associated with the enhanced ability to bind to human cells and multiply.

Epidemiological studies and monitoring data points to a spike in Omicron infections in South Africa that threatens to replace the dominant Delta strain. More research is needed to determine contagiousness.

Q: What is the new strain's impact on vaccines and antibody treatment?

Research shows that three mutations on the virus's spike protein — K417N, E484A and N501Y — are linked to a stronger ability to evade immunity. Omicron carries all three, as well as other mutations that will likely diminish protection provided by antibody drugs.

More research is needed to determine its effect on existing vaccines.

Q: How about its impact on nucleic acid testing kits?

Genome sequencing analysis shows that the mutations will not affect the sensitivity and specificity of mainstream nucleic acid tests in China. Some laboratories in South Africa reported that testing kits being used there likely cannot detect the new strain effectively.

Q: What measures have been taken?

A number of countries and regions, including the United States, the United Kingdom, the European Union, Russia, Israel, the Hong Kong Special Administrative Region and Taiwan have restricted travel from South Africa.

Q: How is China responding?

China's strategy of preventing imported cases and swiftly dealing with local resurgences remains effective against the Omicron strain. The Chinese Center for Disease Control and Prevention has established testing methods for the new strain and will continuously sequence genomes of imported cases to catch possible infections in a timely manner.

Q: What can the public do to protect themselves against the new strain?

Wearing masks remains the most effective way to stem the spread of the virus, including the Omicron variant. It is recommended that all people, including the fully vaccinated and those receiving a booster shot, wear masks in indoor spaces and on public transportation. Regular hand washing and good ventilation are also important.

Given the limited understanding so far of the new strain and risk of infections in China, the public is recommended to avoid traveling to high-risk areas overseas and to step up personal protection during trips.

Source: National Health Commission

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 毛片视频免费网站 | 亚洲欧美日韩专区一 | 中文字幕一区日韩在线视频 | 色午夜婷婷 | 精品一区二区三区在线观看视频 | 三级黄色片免费观看 | 美欧毛片| 欧美午夜激情影院 | 亚洲第一福利视频 | 亚洲第一视频区 | 免费特级黄毛片在线成人观看 | 高清精品| 青青艹视频在线 | 免费高清毛片 | 亚洲欧美中文字幕高清在线一 | 国产女人成人精品视频 | 日韩一区二区超清视频 | 成人亚洲网站 | 成人爱av18丰满 | 亚洲欧美一区二区三区综合 | 99视频只有精品 | 制服丝袜 自拍偷拍 | 97精品国产91久久久久久 | 极品美女一级毛片免费 | 天天综合久久 | 免费一级大黄特色大片 | 性香港xxxxx免费视频播放 | 在线观看色片 | 国产亚洲精品一区二区久久 | 亚洲在线免费免费观看视频 | 中文字幕一区二区三区不卡 | 免费观看黄色一级片 | 国产精品热久久毛片 | 国产欧美日韩在线观看一区二区三区 | 久久久久婷婷国产综合青草 | 亚洲香蕉毛片久久网站老妇人 | 免费看黄色的视频 | 久久精品免费播放 | 欧美激情精品久久久久久不卡 | 国产成人精品亚洲 | 美国美女一级片 |